Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

FKBP51 Activators

Common FKBP51 Activators include, but are not limited to Hydrocortisone CAS 50-23-7, Mifepristone CAS 84371-65-3, Rapamycin CAS 53123-88-9, FK-506 CAS 104987-11-3 and Dexamethasone CAS 50-02-2.

FKBP51, or FK506 binding protein 5, is a member of the immunophilin protein family, which plays a role in immunoregulation and basic cellular processes involving protein folding and trafficking. The protein interacts with various other proteins, acting as a co-chaperone in the regulation of steroid receptor complexes. It is known to have peptidylprolyl isomerase activity, which means it can catalyze the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and accelerate the folding of proteins. FKBP51's role in various cellular processes emphasizes its importance in maintaining cellular homeostasis.

FKBP51 Activators are a specific group of chemical compounds designed to enhance or stimulate the activity or expression of the FKBP51 protein. By promoting the activity of FKBP51, these activators influence a variety of intracellular processes where FKBP51 plays a pivotal role. For example, the modulation of steroid receptor complexes, which are crucial for various signaling pathways within cells, can be influenced by changes in FKBP51 activity. Furthermore, by affecting the peptidylprolyl isomerase activity of FKBP51, these activators may influence protein folding processes within the cell. Such alterations can have profound implications on cellular function, stability, and response to external stimuli. Understanding the mechanistic actions and outcomes of FKBP51 activators can provide deeper insights into cellular biology and the intricate balance of protein interactions and functions.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Hydrocortisone

50-23-7sc-300810
5 g
$102.00
6
(1)

Cortisol, a glucocorticoid, can induce FKBP51 expression as part of its regulation of the glucocorticoid receptor pathway.

Mifepristone

84371-65-3sc-203134
100 mg
$61.00
17
(1)

Mifepristone is a glucocorticoid receptor antagonist. By modulating the receptor's activity, it might influence FKBP51 expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

As an immunosuppressant that binds FKBP51, rapamycin might modulate the expression of FKBP51.

FK-506

104987-11-3sc-24649
sc-24649A
5 mg
10 mg
$78.00
$151.00
9
(1)

FK-506 binds to FKBP51. This interaction might influence the cellular levels of FKBP51.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Dexamethasone, a synthetic glucocorticoid, can induce FKBP51 expression as part of its effect on the glucocorticoid receptor pathway.

Spironolactone

52-01-7sc-204294
50 mg
$109.00
3
(1)

Spironolactone, an aldosterone antagonist, might influence FKBP51 expression through its modulation of steroid receptors.

Temozolomide

85622-93-1sc-203292
sc-203292A
25 mg
100 mg
$91.00
$255.00
32
(1)

Temozolomide, a DNA alkylating agent, induces cellular stress, which might upregulate FKBP51 as a stress response protein.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

As a histone deacetylase inhibitor, valproic acid can modulate gene expression, potentially affecting FKBP51 levels.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

Sulforaphane affects various cellular pathways, including NRF2-mediated oxidative stress responses, which might influence FKBP51 expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Another histone deacetylase inhibitor, vorinostat, might influence FKBP51 expression by modulating chromatin structure and gene expression.